Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Not applicableLooking for participantsNCT06764459
What this trial is testing

Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments

Who this might be right for
Myeloid Leukemia, Acute
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Not applicableStudy completedNCT01772680
What this trial is testing

Zinc and Diabetes in Patients With Thalassemia: a Pilot Study

Who this might be right for
Thalassemia
UCSF Benioff Children's Hospital Oakland 40
Testing effectiveness (Phase 2)Study completedNCT03839446
What this trial is testing

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Who this might be right for
Acute Myeloid Leukemia
Robert Redner, MD 16
Testing effectiveness (Phase 2)UnknownNCT01002703
What this trial is testing

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leipzig 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610438
What this trial is testing

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 76
Testing effectiveness (Phase 2)UnknownNCT00531089
What this trial is testing

Rituximab in Patients With Relapsed or Refractory TTP-HUS

Who this might be right for
Thrombotic Thrombocytopenic PurpuraHemolytic Uremic Syndrome
Hamilton Health Sciences Corporation 60
Not applicableUnknownNCT02582450
What this trial is testing

Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia

Who this might be right for
Haemophilia
Real Fundación Victoria Eugenia 70
Large-scale testing (Phase 3)Study completedNCT00520780
What this trial is testing

Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

Who this might be right for
Chronic Heart FailureIron DeficiencyIron Deficiency Anemia+1 more
Vifor Pharma 456
Early research (Phase 1)Study completedNCT01613976
What this trial is testing

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT01244750
What this trial is testing

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Who this might be right for
Chronic Myeloid Leukemia
Bristol-Myers Squibb 1,494
Early research (Phase 1)Ended earlyNCT04123418
What this trial is testing

WVT078 in Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
Novartis Pharmaceuticals 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Large-scale testing (Phase 3)Study completedNCT01850524
What this trial is testing

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 705
Early research (Phase 1)Active Not RecruitingNCT04874480
What this trial is testing

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Who this might be right for
Recurrent LeukemiaRefractory Leukemia
M.D. Anderson Cancer Center 9
Not applicableUnknownNCT03145896
What this trial is testing

The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients

Who this might be right for
IBD
Tel-Aviv Sourasky Medical Center 40
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT01795690
What this trial is testing

Clinical Tumor Anemia Registry (TAR)

Who this might be right for
Anemia
iOMEDICO AG 1,018
Not applicableStudy completedNCT00186797
What this trial is testing

Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
St. Jude Children's Research Hospital 28
Early research (Phase 1)Ended earlyNCT05338346
What this trial is testing

ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Antengene Discovery Limited 22
Next Page